Lanean...
Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials
OBJECTIVE: Prevention trials for neurodegenerative diseases use genetic or other risk marker tests to select participants but there is concern that this could involve coercive disclosure of unwanted information. This has led some trials to use blinded enrollment (participants are tested but not told...
Gorde:
| Argitaratua izan da: | Neurology |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Lippincott Williams & Wilkins
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4395889/ https://ncbi.nlm.nih.gov/pubmed/25762713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001451 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|